Patients on Osteoporosis’ Medication May Develop Eye Disorder, Say Researchers

.

Patients on Osteoporosis’ Medication May Develop Eye Disorder, Say Researchers

For the very first time, a study has showed that patients on osteoporosis’ medication are at a higher risk of being affected with inflammatory eye disease. The study was conducted by the researchers of Child and Family Research Institute located in Vancouver.

During the study, the researchers examined the effect of osteoporosis’ medication, oral bisphosphonates over eye conditions uveitis and scleritis. During the study, it was found that the patients on bisphosphonates were at higher risk of developing the eye disorders.

The findings of the study have been published in the journal Canadian Medical Association. For the study, the researchers analyzed the data of 934,147 patients. The majority of the patients were not taking the bisphosphonates.

The researchers informed that patients who had been taking bisphosphonates for the very first time were more likely to be affected with uveitis and scleritis. The author of the study noted, “Our study highlights the need for clinicians to inform their patients about the signs and symptoms of scleritis and uveitis, so that prompt treatment may be sought and further complications averted”.

The findings have stirred unrest among the health experts, as it is for the very first time when a study has showed that the osteoporosis’ medication can have adverse outcomes on the health of the patients.


Latest News

Springdale, the Small Utah town Finally Repeals Chain Restaurant Ban After a Dec
Oshkosh Corporation Won a $30billion Contract for Replacing Humvee Units of the
Federal Reserve Vice Chairman Fischer Hints Inflation is Likely to Rebound Permi
Trib Total Media Plans to Sell Nine Newspapers including Four Daily and Five Wee
Twitter Plans to Employ More Women Next Year to Diversify Its Workforce
OPEC Oil Producers Prepared to Endure Lower Oil Prices But will Continue their P
Stanley Fischer Federal Reserve Vice Chairman Says No Decision Has Been Taken fo
Biggest Daily Climb Noted in the Oil Markets in Past Six Years
According to Sources Marchionne to Take over as Both CEO and Chairman of Ferrari
Consumer Spending and Inflation Drops in Japan Adding Pressure on Policymakers
Patterson Companies, Inc reports $29.7 million First Quarter Profit
Gap Announced by Beginning of Next year It will Phase Out On-Call Scheduling